Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Intent to treat
An analysis of data from all the participants in a specific group in a clinical trial, regardless of whether they dropped out of the study or not. Results are based on the initial treatment intent, not on the treatment eventually administered.
See also:
Clinical trial
Data analysis
Drop out
Related terms
Protocol, Pharmacokinetics, Patent, Drivers, Quality of life trials, Treatment trials, Detail aid, Sensitivity to change (pharmacoeconomics), Randomised trial, Adherence, Placebo effect, Institutional review board (IRB) - pharmacoeconomics, Pharmaceutical Researchers and Manufacturers of America (PhRMA), Boston matrix, Informed consent document,
Featured jobs
-
Account Manager
-
£Competitive Salary
-
Account Director, Medical Education
-
Salary TBC
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
-
Account Director
-
£Competitive Salary
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
-
Account director
-
Competitive salary and bonus scheme
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Publications director
-
Competitive salary and bonus scheme
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Director, Healthcare Communications
-
Salary TBC
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
Subscribe to our email news alerts
- 20 for 2020 – Five pharma companies to watch
- BMS unveils long-term results for Opdivo in kidney cancer
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Categories - Communiqué Awards
- Seattle Genetics wins FDA priority review for oral HER2 drug
- AbbVie/Allergan merger faces renewed public opposition despite divestments
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Researchers discover new antibiotic using AI
- Bedrock Group celebrates a trio of new hires
- Tocagen merges with Forte Biosciences after brain cancer fail
- Immutep spikes on trial of its LAG-3 drug with Keytruda
PMHub
90TEN
90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...
Quick links
Infographics
